Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 3 days ago Contract award

Poland - Pharmaceutical products - NZP.271.45.2026 Public procurement procedure for the supply of medicinal products - DRUG PROGRAMMES for the Copernicus Multidisciplinary Oncology and Traumatology Centre in Lodz, open tender procedure above EUR 10,000,000

Original Polska - Produkty farmaceutyczne - NZP.271.45.2026 Postępowanie o udzielenie zamówienia publicznego na dostawę produktów leczniczych - PROGRAMY LEKOWE dla Wojewódzkiego Wielospecjalistycznego Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi prowadzonego w trybie przetargu nieograniczonego o wartości powyżej 10 000 000 Euro.

Awarded Poland Łódzkie Medical equipment & pharmaceuticals

Buyer Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi

€6.9M awarded value · €6,923,392

Key facts

Published
Procedure
Open procedure
  1. Published
  2. Awarded pending

TED - Tenders Electronic Daily (Publications Office of the EU) does not publish the date of this award. See the official notice

View the official notice Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

Awarded to

Salus International Sp. z o.o.; Takeda Pharma Sp. z o.o.; FARMACOL LOGISTYKA Sp. z o.o.; Urtica Sp. z o.o.; Asclepios S.A.; Lek S.A.

Awarded value
€6,923,392
Bids received
15 over 15 lots
Record with this buyer
1 first contract from this buyer in the register

Summary

Machine-generated summary

The Copernicus Multidisciplinary Oncology and Traumatology Centre in Lodz awarded a contract for the supply of medicinal products under drug programmes. The procurement was divided into 15 packages covering medicines such as Letermovirum, Ixazomibum, Inclisiranum, Darolutamidum, Alpelisibum, Talazoparibum, Interferonum beta-1b, Fingolimodum, Lamivudinum and botulinum toxin type A. The contract was won by a group of six companies: Salus International Sp. z o.o., Takeda Pharma Sp. z o.o., FARMACOL LOGISTYKA Sp. z o.o., Urtica Sp. z o.o., Asclepios S.A. and Lek S.A. The awarded value was EUR 6,923,392.08.

Description

Przedmiotem zamówienia jest dostawa produktów leczniczych - PROGRAMY LEKOWE . Przedmiot zamówienia jest zamówieniem prowadzonym w częściach i obejmuje 15 pakietów. Zamawiający określił szczegółowy opis przedmiotu zamówienia oraz warunki bezwzględnie wymagane, które muszą zostać spełnione przez oferowany przedmiot zamówienia w treści załącznika nr 2 oraz we wzorze umowy . 1 Letermovirum Tabletki powlekane 240 mg 2 Letermovirum Tabletki powlekane 480 mg Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Ixazomibum Kapsułki twarde 2,3 mg 2 Ixazomibum Kapsułki twarde 3 mg 3 Ixazomibum Kapsułki twarde 4 mg Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Inclisiranum Roztwór do wstrzykiwań w ampułko-strzykawce 284 mg/1,5 ml Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Darolutamidum Tabletki powlekane 300 mg Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Alpelisibum Tabletki powlekane 150 mg 2 Alpelisibum Tabletki powlekane 200 mg 3 Alpelisibum Tabletki powlekane 50 mg; 200 mg Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Talazoparibum Kapsułki twarde 1 mg 2 Talazoparibum Kapsułki twarde 0,25 mg Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Interferonum beta-1b Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań 250 mcg/ml Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Fingolimodum Kapsułki twarde 0,5 mg Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Lamivudinum Tabletki powlekane 100 mg Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Toxinum botulinicum typum A ad iniectabile, zarejestrowana w programach <1>B.28.; <2>B.30.; <3>B.57.; <4>B.73. Proszek do sporządzania roztworu do wstrzykiwań 100 jednostek Allergan kompleksu neurotoksyny Clostridium botulinum typu A/fiolkę Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Certolizumabum pegol Roztwór do wstrzykiwań w ampułko-strzykawce 200 mg Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Apomorphini hydrochloridum hemihydricum Roztwór do infuzji 5 mg/ml 2 pozycja 2A: D-mine Reservoir i pozycja 2B: D-mine Infset, które zapewniają prawidłową administrację leku w ramach programu B.90. Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Interferonum beta-1a (typu Rebif) Roztwór do wstrzykiwań 44 μg/0,5 ml (12 mln j.m/ml) Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Ixekizumabum Roztwór do wstrzykiwań 80 mg/ml Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.; 1 Adalimumabum roztwór do wstrzykiwań 40 mg /wstrzykiwacz Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ.

15 lots

Lot 1
Pakiet nr 1 24 months
Lot 2
Pakiet nr 2 24 months
Lot 3
Pakiet nr 3 24 months
Lot 4
Pakiet nr 4 24 months
Lot 5
Pakiet nr 5 24 months
Lot 6
Pakiet nr 6 24 months
Lot 7
Pakiet nr 7 24 months
Lot 8
Pakiet nr 8 24 months
How tenders are scored
Price: 100 points
Show 7 more lots
Lot 9
Pakiet nr 9 24 months
Lot 10
Pakiet nr 10 24 months
Lot 11
Pakiet nr 11 24 months
Lot 12
Pakiet nr 12 24 months
Lot 13
Pakiet nr 13 24 months
Lot 14
Pakiet nr 14 24 months
Lot 15
Pakiet nr 15 24 months

As the official notice states them.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 3 days ago

What this buyer has paid before

Based on 199 comparable contracts this buyer awarded in this sector over the last 4 years.

This award
€6.9M
Median award
€389,362
Middle half of past awards
€114,784 to €1.3M

The award is larger than three in four past awards.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi

Poland

notices in the register
967
awards
358
awarded in total
€1.2B

Who wins its contracts

Many suppliers
different companies won its awards
275
of the awards went to the three most frequent winners
5%
of its calls state an estimated value
0%

Based on 321 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.6
of those lots received a single tender
70%
of the awards went to companies based in another country
3%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Awards most often to

  1. ASCLEPIOS S.A. 6 awards €314,189
  2. TMS Sp. z o.o. 5 awards €2.2M
  3. Astrazeneca Kft. 4 awards €12.1M

13 open tenders right now

Market context

open now in Medical equipment & pharmaceuticals
8,536
median open notice
€294,396

Who wins in this market

Many suppliers

Poland · Medical equipment & pharmaceuticals

different companies won awards here
13,478
of the awards went to the three most frequent winners
4%
buyers awarded contracts here
1,464

Based on 23,086 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.8
of those lots received a single tender
63%
of the awards went to companies based in another country
2%
of the tenders came from another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Procedure facts

  • Each of its 15 lots received a single tender (open procedure).

Facts that procurement researchers and journalists track across public records. None of them is evidence of wrongdoing: each has ordinary explanations, such as a specialised market, an urgent need or a short list of qualified suppliers.

Similar tenders

Open now

Awarded before

Never miss a tender like this

963 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language